Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1261615

The design of compounds with desirable properties–The anti-HIV case study


Novak, Jurica; Pathak, Prateek; Grishina, Maria A.; Potemkin, Vladimir A.
The design of compounds with desirable properties–The anti-HIV case study // Journal of Computational Chemistry, 44 (2023), 10; 1016-1030 doi:10.1002/jcc.27061 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1261615 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The design of compounds with desirable properties–The anti-HIV case study
(The design of compounds with desirable properties – The anti‐HIV case study)

Autori
Novak, Jurica ; Pathak, Prateek ; Grishina, Maria A. ; Potemkin, Vladimir A.

Izvornik
Journal of Computational Chemistry (0192-8651) 44 (2023), 10; 1016-1030

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
3CLpro ; cytotoxicity ; drug repurposing ; HIV-1 protease ; QSAR

Sažetak
Efficacy and safety are among the most desirable characteristics of an ideal drug. The tremendous increase in computing power and the entry of artificial intelligence into the field of computational drug design are accelerating the process of identifying, developing, and optimizing potential drugs. Here, we present novel approach to design new molecules with desired properties. We combined various neural networks and linear regression algorithms to build models for cytotoxicity and anti-HIV activity based on Continual Molecular Interior analysis (CoMIn) and Cinderella's Shoe (CiS) derived molecular descriptors. After validating the reliability of the models, a genetic algorithm was coupled with the Des-Pot Grid algorithm to generate new molecules from a predefined pool of molecular fragments and predict their bioactivity and cytotoxicity. This combination led to the proposal of 16 hit molecules with high anti-HIV activity and low cytotoxicity. The anti-SARS-CoV-2 activity of the hits was predicted.

Izvorni jezik
Hrvatski

Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti



POVEZANOST RADA


Ustanove:
Sveučilište u Rijeci - Odjel za biotehnologiju

Profili:

Avatar Url Jurica Novak (autor)

Poveznice na cjeloviti tekst rada:

doi onlinelibrary.wiley.com

Citiraj ovu publikaciju:

Novak, Jurica; Pathak, Prateek; Grishina, Maria A.; Potemkin, Vladimir A.
The design of compounds with desirable properties–The anti-HIV case study // Journal of Computational Chemistry, 44 (2023), 10; 1016-1030 doi:10.1002/jcc.27061 (međunarodna recenzija, članak, znanstveni)
Novak, J., Pathak, P., Grishina, M. & Potemkin, V. (2023) The design of compounds with desirable properties–The anti-HIV case study. Journal of Computational Chemistry, 44 (10), 1016-1030 doi:10.1002/jcc.27061.
@article{article, author = {Novak, Jurica and Pathak, Prateek and Grishina, Maria A. and Potemkin, Vladimir A.}, year = {2023}, pages = {1016-1030}, DOI = {10.1002/jcc.27061}, keywords = {3CLpro, cytotoxicity, drug repurposing, HIV-1 protease, QSAR}, journal = {Journal of Computational Chemistry}, doi = {10.1002/jcc.27061}, volume = {44}, number = {10}, issn = {0192-8651}, title = {The design of compounds with desirable properties–The anti-HIV case study}, keyword = {3CLpro, cytotoxicity, drug repurposing, HIV-1 protease, QSAR} }
@article{article, author = {Novak, Jurica and Pathak, Prateek and Grishina, Maria A. and Potemkin, Vladimir A.}, year = {2023}, pages = {1016-1030}, DOI = {10.1002/jcc.27061}, keywords = {3CLpro, cytotoxicity, drug repurposing, HIV-1 protease, QSAR}, journal = {Journal of Computational Chemistry}, doi = {10.1002/jcc.27061}, volume = {44}, number = {10}, issn = {0192-8651}, title = {The design of compounds with desirable properties – The anti‐HIV case study}, keyword = {3CLpro, cytotoxicity, drug repurposing, HIV-1 protease, QSAR} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font